Related Experiment Video
Updated: Jul 9, 2026

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
Prophylactic human papillomavirus vaccination: a breakthrough in primary cervical cancer prevention
Francisco A R Garcia1, Debbie Saslow
1Obstetrics and Gynecology, Public Health and Mexican-American Studies, National Center of Excellence in Women's Health, The University of Arizona, University Medical Center, 1501 North Campbell Avenue, Tucson, AZ 85724, USA. fcisco@u.arizona.edu
Abstract:
Nearly all cervical cancers require human papillomavirus infection (HPV) for subsequent carcinogenesis. The identification of this obligate viral etiology, in addition to a vast knowledge about the HPV viral life cycle and resultant host response, has led to a vaccine approach to cervical cancer prevention. The use of prophylactic cancer vaccine as primary prevention holds the most promise for long-term cancer prevention but raises some important and as yet unanswered questions that are addressed in this article.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Prevention
Some...
Cancer Prevention
Some...
Preventive Healthcare Services
Smallpox
Mechanisms of Retrovirus-induced Cancers